glp-1 cardiovascular outcomes news today medications are known for their weight-loss effects, but fewer people may know that they could benefit the heart too. In fact, Wegovy was approved by the FDA to reduce the risk Cardiovascular outcomes trials for GLP-1

Those with a BMI below 30 may want to consider dieting and exercise before considering semaglutide shots

Most patients experience minimal discomfort , similar to a blood draw

The FDA's Pharmacy Compounding Advisory Committee is reviewing whether BPC 157 presents significant safety risks and whether compounding pharmacies should be permitted to prepare it as a bulk substance

Individual calorie requirements on GLP-1 therapy depend on numerous physiological and lifestyle factors that must be considered for personalised nutritional planning

Because Thiamine is essential for glucose metabolism, it plays a key role in nerve, muscle and heart function